SIRT1 deficiency attenuates MPP+-induced apoptosis in dopaminergic cells

FEBS Letters

Volumn 585, Issue 1, 2011, Pages 219-224

  Park, Geunyeong ^a   Jeong, Joo Won ^a   Kim, Ja Eun ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

1 Methyl 4 phenylpyridinium; Apoptosis; BNIP2; Parkinson's disease; Sirtuin 1

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BCL XL; PROTEIN BNIP2; SIRTUIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION;

1-METHYL-4-PHENYLPYRIDINIUM; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; NEUROBLASTOMA; POLY(ADP-RIBOSE) POLYMERASES; RNA INTERFERENCE; SIRTUIN 1;

EID: 78650919036     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.11.048     Document Type: Article

References (36)

1. J.N. Feige, and J. Auwerx Transcriptional targets of sirtuins in the coordination of mammalian physiology Curr. Opin. Cell Biol. 20 2008 303 309
2. N. Dali-Youcef, M. Lagouge, S. Froelich, C. Koehl, K. Schoonjans, and J. Auwerx Sirtuins: the 'magnificent seven', function, metabolism and longevity Ann. Med. 39 2007 335 345
3. M.C. Haigis, and D.A. Sinclair Mammalian sirtuins: biological insights and disease relevance Annu. Rev. Pathol. 5 2010 253 295
4. D. Kim SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis EMBO J. 26 2007 3169 3179
5. D. Albani The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide J. Neurochem. 110 2009 1445 1456
6. J. Chen, Y. Zhou, S. Mueller-Steiner, L.F. Chen, H. Kwon, S. Yi, L. Mucke, and L. Gan SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling J. Biol. Chem. 280 2005 40364 40374
7. G. Donmez, D. Wang, D.E. Cohen, and L. Guarente SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10 Cell 142 2010 320 332
8. W. Qin Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction J. Biol. Chem. 281 2006 21745 21754
9. T. Araki, Y. Sasaki, and J. Milbrandt Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration Science 305 2004 1010 1013
10. J.A. Parker, M. Arango, S. Abderrahmane, E. Lambert, C. Tourette, H. Catoire, and C. Neri Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons Nat. Genet. 37 2005 349 350
11. +-induced cytotoxicity in neuronal PC12 cells J. Neurosci. Res. 70 2002 90 96
12. M. Okawara, H. Katsuki, E. Kurimoto, H. Shibata, T. Kume, and A. Akaike Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults Biochem. Pharmacol. 73 2007 550 560
13. D. Alvira, M. Yeste-Velasco, J. Folch, E. Verdaguer, A.M. Canudas, M. Pallas, and A. Camins Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons Neuroscience 147 2007 746 756
14. J. Blanchet, F. Longpre, G. Bureau, M. Morissette, T. DiPaolo, G. Bronchti, and M.G. Martinoli Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1243 1250
15. K.T. Lu Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging J. Agric. Food Chem. 56 2008 6910 6913
16. +-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons Cell. Mol. Neurobiol. 29 2009 1169 1180
17. J. Chao, M.S. Yu, Y.S. Ho, M. Wang, and R.C. Chang Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity Free Radic. Biol. Med. 45 2008 1019 1026
18. F. Jin, Q. Wu, Y.F. Lu, Q.H. Gong, and J.S. Shi Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats Eur. J. Pharmacol. 600 2008 78 82
19. M. Pacholec SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1 J. Biol. Chem. 285 2010 8340 8351
20. D. Beher, J. Wu, S. Cumine, K.W. Kim, S.C. Lu, L. Atangan, and M. Wang Resveratrol is not a direct activator of SIRT1 enzyme activity Chem. Biol. Drug Des. 74 2009 619 624
21. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
22. J.S. Choi, C. Park, and J.W. Jeong AMP-activated protein kinase is activated in Parkinson's disease models mediated by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine Biochem. Biophys. Res. Commun. 391 2010 147 151
23. B. Dasgupta, and J. Milbrandt Resveratrol stimulates AMP kinase activity in neurons Proc. Natl. Acad. Sci. USA 104 2007 7217 7222
24. D.E. Merry, and S.J. Korsmeyer Bcl-2 gene family in the nervous system Annu. Rev. Neurosci. 20 1997 245 267
25. C. Meda, E. Vegeto, G. Pollio, P. Ciana, C. Patrone, C. Pellicciari, and A. Maggi Oestrogen prevention of neural cell death correlates with decreased expression of mRNA for the pro-apoptotic protein NIP-2 J. Neuroendocrinol. 12 2000 1051 1059
26. Z.Z. Chong, S.H. Lin, F. Li, and K. Maiese The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through AKT, BAD, PARP, and mitochondrial associated "anti-apoptotic" pathways Curr. Neurovasc. Res. 2 2005 271 285
27. M.A. Holland, A.A. Tan, D.C. Smith, and M.R. Hoane Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury J. Neurotrauma 25 2008 140 152
28. Y. Li, W. Xu, M.W. McBurney, and V.D. Longo SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons Cell Metab. 8 2008 38 48
29. J.E. Kim, J. Chen, and Z. Lou DBC1 is a negative regulator of SIRT1 Nature 451 2008 583 586
30. F. Yeung, J.E. Hoberg, C.S. Ramsey, M.D. Keller, D.R. Jones, R.A. Frye, and M.W. Mayo Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase EMBO J. 23 2004 2369 2380
31. J.M. Boyd, S. Malstrom, T. Subramanian, L.K. Venkatesh, U. Schaeper, B. Elangovan, C. D'Sa-Eipper, and G. Chinnadurai Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins Cell 79 1994 341 351
32. E. Vegeto, G. Pollio, C. Pellicciari, and A. Maggi Estrogen and progesterone induction of survival of monoblastoid cells undergoing TNF-alpha-induced apoptosis FASEB J. 13 1999 793 803
33. S. Belcredito, E. Vegeto, A. Brusadelli, S. Ghisletti, P. Mussi, P. Ciana, and A. Maggi Estrogen neuroprotection: the involvement of the Bcl-2 binding protein BNIP2 Brain Res. Brain Res. Rev. 37 2001 335 342
34. Y.T. Zhou, U.J. Soh, X. Shang, G.R. Guy, and B.C. Low The BNIP-2 and Cdc42GAP homology/Sec14p-like domain of BNIP-Salpha is a novel apoptosis-inducing sequence J. Biol. Chem. 277 2002 7483 7492
35. A. Sall Pro-apoptotic activity of mBNIP-21 depends on its BNIP-2 and Cdc42GAP homology (BCH) domain and is enhanced by coxsackievirus B3 infection Cell. Microbiol. 12 2010 599 614
36. P. Oberdoerffer SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging Cell 135 2008 907 918